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Introduction: One of the main problems of chronic patients, especially patients with Multiple 
Sclerosis (MS), is negative emotion. The purpose of this study was to investigate the effectiveness 
of group reality therapy in reducing stress, anxiety and depression in patients with multiple sclerosis 
(MS).  
Methods: A total of 40 patients with MS at the Multiple Sclerosis Society of Iran were selected and 
randomly divided into two groups of experimental and control (N=20 subjects). All participants 
before and after the intervention to scale DASS-21 responded. The experimental group received 
eight sessions of reality therapy and the control group received no intervention. The data of pre-test 
and post-test were analyzed using descriptive and inferential statistics (analysis of covariance).    
Results: Findings showed a significant reduction in the mean of the three variables of stress (F 
(1.38) = 81.37; p < 0.01) anxiety (F (1.38) = 81.89; p < 0.01) and depression (F (1.38) = 82.56; P < 
0.01) in the experimental group after the intervention (p < 0.05) 
Conclusion: in this study group reality therapy significantly reduces stress, anxiety and depression 
in the intervention group compared with the control group. The reality therapy can be an effective 
therapy in the treatment of stress, anxiety and depression in patients with MS and as an adjunct to 
other therapies.  
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     Introduction  
      Multiple Sclerosis (MS) is one of the central 
nervous system diseases in which the myelin 
sheath progressively dwindles away and affects 
the sensory and motor functioning (1). The 
disease is one of the most common neurological 
diseases in humans, and is the most disabling 
disease in youth. The most common age of its 
onset is in the young age, and its prevalence is 
about twice in women than men (2). 
Chronic diseases such as multiple sclerosis, in 
addition to physical health problems, cause 
numerous psychological disorders in patients as 




Evaluating depression and anxiety in patients 
with MS performed on 120 patients in Norway, 
according to the results, 31.4% and 19.3% of 
patients reported symptoms of depression and 
anxiety, respectively. The study revealed that the 
depression symptoms and anxiety symptoms 
respectively occur almost twice and three times 
more among the patients with multiple sclerosis 
compared with the general population in Norway 
(4). Stress, as a multi-dimensional and multifactorial 
phenomenon can be considered as a complication 
of the Multiple Sclerosis disease as well as a 
factor in aggravation or recurrence of the symptoms 
caused by the disease (5). Stress can sometimes  
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be life-threatening for the patients, including factors 
of divorce, loss of job and family conflicts (6).  
Depression is experienced by 50% to 60% of 
patients, which can be the cause or effect of 
fatigue in endogenous and relapsing forms. The 
suicide rate in these patients is approximately 7.5 
times higher than the control group (7). 
Depression and anxiety may increase the fatigue. 
Depression may be caused by poor quality sleep 
and nutrition, or might be associated with a 
general feeling of depression. It is important to 
diagnose the cause to pursue the proper 
pharmacological and psychological treatments 
(8). Although, anxiety is another debilitating 
symptom in these patients, but it has been less 
studied. According to the research literature, its 
prevalence has been reported varied. In a study on 
patients recently diagnosed by the disease, anxiety 
has been reported in 34% of patients and in 40% 
of their parents (9). The exact cause of high rates 
of depression and anxiety in these patients is 
unknown. It is believed that a combination of 
psychosocial and neurological factors related to 
the disease are likely involved (10). In a study by 
Thornton et al. (2007), the rate of worry in MS 
patients and the relationship between worry and 
anxiety and depression in these patients were 
investigated in a case-control study. The results 
showed that anxiety and depression scores in 
patients with MS were higher than the control 
group, the MS patients’ concerns included two 
parts: The patients' concern about the impact of the 
disease on their physical activity and their 
concern about the disease severity effect on social 
interactions, family relationships and daily activities 
at home or work (3). Studies have also shown that 
patients with multiple sclerosis have much higher 
levels of psychiatric disorders such as depression, 
stress and anxiety compared to the healthy 
subjects. These symptoms may be due to the 
direct effect of inflammation and demyelination 
of nerves or related to the psychological impacts 
of the chronic and unpredictable multiple sclerosis. 
The mental manifestations of this disease include 
anxiety, stress, depression, cognitive disorders, 
irritability and the anger that among them, anxiety, 
stress and depression have the most prevalence in 
patients with multiple sclerosis (11). Approximately 
48% of patients experience the symptoms of 
stress, anxiety and depression in the first year 
after the diagnosis (12).  
The positive psychology approach of “choice 
theory” and “reality therapy” occurs in the areas 
of psychiatry, psychology and behavioral sciences. 
In 1965, William Glasser provided a new theory 
about the psychopathology of mental and 
behavioral disorders and their treatment methods 
that was called by hem “reality therapy”. In 
general, “choice theory” explains that “why” and 
“how” the people behave. This theory explains 
the human brain functioning in managing the 
behaviors.  
Glasser believed that failing to meet the basic 
needs is a general and universal experience, since 
the “reality” is not always synchronized and 
consistent with us. However, some people failed 
to meet their needs act irresponsible instead of 
accepting their responsibility and searching for 
other effective ways to satisfy their needs and act 
responsibly to meet them (13).  
The physiological component was introduced at 
the beginning addressed in MS and damages to 
the myelin. However, the emotion component of 
the general behavior is also involved in MS 
patients and disturbs the mood and trends. The 
research carried out in the 1960s and 1970s 
focused on these intrinsic processes to realize the 
daily lives of people with MS. Despite the help of 
technology in describing the physiological states 
and the recognition process, understanding these 
inner states as a way to understand one's own self 
is recommended (14). The component of thinking, 
cognition and brain functions are also much 
affected by multiple sclerosis. Long-term studies 
have found an important brain weakness for those 
with fewer and milder inabilities over one or two 
years (15). The most common characteristic 
depends on changes occurring in the perceptions. 
However, about 24% of people with MS have the 
potential to generally reduce the rate of disease 
progression through interventions such as meta-
cognitive therapy. Although this does not make 
an important difference in the accuracy of the 
disease process, and finally, the functioning 
component as the most effective wheel in the 
behavior machine directly and immediately 
affected by the choices of individuals would 
influence the multiple sclerosis, but unfortunately, a 
large number of MS patients in practice component 
emphasize on those things they cannot do (14). 
This results in inefficient choices and sometimes 
failure to do specific actions and a tendency 
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toward dependence on others to perform their 
affairs.  
In their studies on reality therapy and MS, Kelsh 
et al. (2002) concluded that reality therapy has a 
significant influence on quality of life of MS 
patients (16). In his study as “reality therapy and 
MS”, Ahmadian came to the conclusion that 
reality therapy is effective on increasing the 
quality of life and further adaptability of people 
with the disease. Also in a similar study entitled 
as “Effectiveness of reality therapy in reducing 
anxiety in elementary school pupils”, Shafiabadi 
et al. (17) concluded that the reality therapy is 
effective in reducing anxiety. Cato Shaman study 
(18) showed that the reality therapy functions 
effectively in the management of chronic pains 
and increasing the coping skills. Akahoori (19) 
also demonstrated the effectiveness of reality 
therapy on mood control in a case of advanced 
endometrial carcinoma. In a study by Ali Pasha 
and Amini (20), the reality therapy significantly 
decreased the anxiety of martyrs’ wives.  
Reality therapy process is somehow an invitation 
to take responsibility and use of creative and 
responsible approaches to satisfy the needs. There 
are controversial results about the impacts of 
different treatment methods on controlling the 
psychological consequences. As a result, the 
reality therapy was evaluated in this study to clarify 
whether this method is effective in improving the 
psychological symptoms of MS patients or not. 
 
 Methods 
     This was a quasi-experimental design with 
pre-test, post-test and control group approach. 
The study population included all patients with 
MS referred to the MS Society in Tehran in June 
2015. Data collection lasted 3 months. As clinical 
literature suggests the appropriate number of 
members of a therapy group intervention between 
8 and 12 members (17) and experimental studies 
usually use samples with 15-20 subjects for each 
group (18), the sample size was considered as 40 
subjects. The samples were selected by available 
method based on the inclusion criteria and 
randomly divided into two groups (control and 
intervention, each of the 20 subjects). The inclusion 
criteria included: 
Diagnosis of relapsing MS, type of recurrence-
suppression,  not using psychiatric drugs and 
psychological therapies during the study, age 
between 20 and 40 years, non-developing other 
acute or chronic disorders, no hearing or speech 
problems, consent to participate in the research. 
After selecting the subjects, first, the research 
purpose, duration and the benefits of participating 
in the study were explained to them. They were 
told that they will participate in a study and all 
the information taken would remain confidential. 
Subsequently, a written consent was obtained from 
them, and they were assessed by the researcher 
using an inventory. 
Since dealing with feelings in group interaction is 
not a structured method, thus, the focus of all 
sessions is on the emotions occurring here and 
now within the group. After explaining the 
treatment logic and methodology for the subjects 
and removing ambiguity regarding group meetings, 
the first session began. The intervention plan, 
involving the performance of the group reality 
therapy, was conducted on the experimental 
group for 8 sessions in MS Society in Tehran. 
The focus of sessions was on the selection, 
responsibility and expressing feelings here and 
now. In most of the session, people were helped 
to realize the differences of their thoughts, 
feelings and behaviors and get knowledge of the 
impact of these components on each other. At the 
end of each session, the experiences of the 
participants during the session were discussed. 
Also, an emotional feedback was taken from the 
people of the whole session, and according to 
what they had experienced, the required feedback 
should be given. At the end of program after one 
week, both experimental and control groups again 
completed the DASS-21 questionnaire as a post-
test. The data was evaluated using the SPSS 
software (version 16) and analyzed using 
covariance descriptive and inferential statistics. 
The analysis of covariance of pre-test scores was 
controlled and to assess the effect of the 
independent variable, the post-test scores were 
examined. 
Depression, anxiety and stress scale (DASS-21) 
The DASS-21 Scale (laviband and laviband, 
1995) contains 21 questions, in which 7 questions 
are used to measure each of the symptoms of 
anxiety, stress and depression. The scale was 
designed in a Likert form with options of never, 
low, moderate and high. The lowest and highest 
scores of each question are equal to zero and 3. 
The instrument rating on stress, anxiety and 
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depression is defined as the sum of scores 
between 0 and 4 as normal, 5 to 11 as moderate 
as and higher than 12 as severe (labivand, 1995). 
Anthony et al. (21) analyzed the mentioned scale. 
The study results again suggested the presence of 
three psychological factors of depression, anxiety 
and stress. The results showed that 68% of the 
scale total variance are assessed by these three 
factors. The special values of stress, anxiety and 
depression factors in the study were respectively 
as 9.07, 2.89 and 1.23, while the alpha coefficients 
for these factors were respectively as 0.97, 0.92 
and 0.95. Also, the results of calculating the 
correlation among the factors in Anthony et al. 
study suggested a correlation of 48% between 
stress and depression, 53% correlation between 
anxiety and stress, and the 28% correlation 
between anxiety and depression (21).  
Samani and Jokar studied the validity and 
reliability of scale in Iran. The test-retest reliability 
for depression, anxiety and stress were reported 
respectively as 80%, 76% and 77%, while the 
Cronbach's alpha for DDSS was reported as 81%, 
74%, and 78%, respectively. The validity of 
divergent, convergent and structure (factor 
analysis) was also proved (22). 
 
 Results  
     The indices of descriptive statistics of 
experimental and control groups before and after 
the test are given in the table below. Also, to assess 
the means difference (between pre-test and post-
test), the covariance test (for controlling the pre-test 
scores) was used. Some of the test assumptions 
were examined before implementing. The results of 
these assumptions as well as the results of analysis 
of covariance in the experimental group are 
presented separately. 
 
Table 1. Mean and standard deviation in both experimental and control groups 
Control Group Experimental Group 
Variables Stages 
SD Mean SD Mean 
3.52 14.35 3.46 14.30 Stress 
 
3.37 13.35 3.74 13.40 Anxiety 
2.92 11.55 2.43 13.30 Depression Pre-test 
3.45 14.85 2.05 10.15 Stress  
2.91 13.95 2.68 9.60 Anxiety 
Post-test 
2.67 12.70 2.25 9.30 Depression 
 
As can be seen, the mean of pre-test scores of two 
experimental and control groups are not much 
different from each other. However, the mean of 
post-test scores in the experimental group in all 
three variables of stress, anxiety and depression is 
less than the pre-test stage in both groups, which  
 
 
indicates the effectiveness of the treatment 
intervention. 
The analysis of covariance was used to investigate 
the significance of the difference between means 
(whether the stress reduction is significant or 
not?) and also to control the pre-test effect. 
Table 2. The analysis of covariance of stress, anxiety and depression variable 
Eta P F Mean of Squares df Ss Source of variations 
0.13 0.23 6.06 13.85 1 13.85 Stress Covariance 
0.12 0.34 2.70 5.35 1 5.35 Anxiety 
0.14 0.21 4.45 8.56 1 8.56 Depression 
0.66 0.00 81.37 182.28 1 182.28 Stress  
Experimental 
Group 
0.63 0.00 81.89 162.15 1 162.15 Anxiety 
0.67 0.00 82.56 158.53 1 158.53 Depression 
 
 In stress variable, the Levine's test showed that 
the error variances of the dependent variable in 
the  two  groups are  identical.   The covariance  
 
analysis table shows that the stress in pre-test, as 
a covariate did not have significant effect on the 
post-test (F = 6.06, p = 0.23). According to table 
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2, the grouping variable (independent) has created 
a significant difference in the group, and explained 
66% of the dependent variable changes. According 
to the analysis of covariance table, the group 
reality therapy had a significant effect on reducing 
stress in patients with MS. 
The analysis of covariance was used to investigate 
the significance of the difference between means 
(whether the anxiety reduction is significant or 
not?) and also to control the pre-test effect. 
In anxiety variable, the Levine's test showed that 
the error variances of the dependent variable in 
the two groups are identical. The covariance 
analysis table shows that the anxiety in pre-test, 
as a covariate had no significant effect on the 
post-test (F = 2.70, p = 0.34). According to table 
4, the grouping variable (independent) has created 
a significant difference in the group, and explained 
63% of the dependent variable changes. According 
to the analysis of covariance table, the group 
reality therapy had a significant effect on reducing 
anxiety in patients with MS. 
The analysis of covariance was used to investigate 
the significance of the difference between means 
(whether the depression reduction is significant or 
not?) and also to control the pre-test effect. 
In depression variable, the Levine's test showed 
that the error variances of the dependent variable 
in the two groups are identical. The covariance 
analysis table shows that the depression in pre-
test, as a covariate had no significant effect on the 
post-test (F = 4.45, p = 0.21). According to table 
6, the grouping variable (independent) has created 
a significant difference in the group, and 
explained 67% of the dependent variable changes. 
According to the analysis of covariance table, the 
group reality therapy had a significant effect on 
reducing depression in patients with MS. 
 
 Conclusion 
      Multiple Sclerosis with its debilitating, chronic 
and unpredictable characteristics creates many 
challenges in the lives of patients. According to 
the young age within which the disease starts, the 
patients have to reconsider the programs of life, 
family and work and face the disease recurrence 
and loss of autonomy, causing abundant anxiety 
and worry (23). Negative emotions (such as 
depression, stress and anxiety) in MS patients are 
usually associated with regard to low quality of 
life. Considering the levels of neurological 
damage in these patients, the treatment of 
psychological symptoms such as depression and 
anxiety plays a decisive role in improving their 
quality of life. Interventions that increase personal 
development, sense of control and finding 
meaning in life are effective in improving the 
quality of life of negative emotions of these 
patients (24). The study results showed that the 
group reality therapy is effective on depression, 
stress and anxiety of patients with MS. The 
intervention group received intervention measures 
of expressing emotions in group interactions 
showed a significant decrease in symptoms of 
depression and anxiety in comparison to the 
control group with no intervention. This conclusion 
is consistent with the results of other studies in 
this area (16, 17, 18, 20). The group reality 
therapy is effective in improving negative 
emotions of such patients. One of the benefits of 
participating in group sessions is to enable 
individuals to express their feelings and ask 
questions. Most of the times, questions and 
answers are associated with some important 
information about the people and help them 
meanwhile expressing their feelings, learn how to 
cope with these unpleasant feelings. Finally, such 
information can lead to a reduction in anxiety and 
worry (25). With regard to the group nature of the 
intervention in the study, it includes many of the 
above components such as empathy, expressing 
feelings, engagement, sharing in experience and 
increasing the internal control feeling. These 
components are among factors that can improve 
the psychological state, especially anxiety and 
depression of patients. The study results also 
confirmed this conclusion. Today, it has been 
determined that psychological stress can activate 
MS (26). Thus, based on the present study, the 
group reality therapy improves the psychological 
status of patients with MS, which in turn reduces 
the rate of recurrence in these patients. This can 
be used as an effective approach in addition to 
medication alone with an important role in 
improving the quality of life of these patients. 
This study, like any other research, has its own 
certain limitations, including lack of follow-up 
course due to the unavailability of patients. 
Subsequently, it is recommended to use follow-up 
courses in future research. Also according to the 
study results, it is suggested that the specialists 
involved in the treatment of MS patients would 
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use this therapeutic method as an effective 
complementary therapy approach. 
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